Portfolio company
OMIC
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This life science technology company develops next-generation sequencing and multiomics platforms for researchers and clinicians to advance science and medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mission Bio
This company develops single-cell multi-omics analysis platforms for researchers and clinicians to enable precision medicine and drug development.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Element Biosciences
Element Biosciences develops DNA sequencing platforms and multi-omics tools for researchers and diagnostic laboratories in the life sciences and genomics sectors.
Motley Bio
This company develops multi-omic sequencing technology for disease detection and drug discovery services for biotechnology and pharmaceutical firms.
Standardbiotools
This company develops genomic and proteomic analytical instruments and consumables for life sciences researchers focused on human health breakthroughs.
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
